Tinostamustine Conditioning and Autologous Stem Cell

Clinical trial NCT03687125 · TERMINATED

Trial details

NCT number: NCT03687125
Sponsor: Mundipharma-EDO GmbH
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Multiple Myeloma in Relapse Multiple Myeloma Progression Multiple Myeloma With Failed Remission

Start date: 2018-10-15
Primary completion: 2019-04-17
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.